MS patients treated with a beta-interferon are often advised to self-inject before going to bed to improve the tolerability of flu-like symptoms. But a study in France has found that patients with intolerable side effects may benefit from a switch to morning injections (Nadjar et al. Clin Neurol Neurosurg 2011; 113: 316-322).